About 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide
2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide (PubChem CID 46943241) has the molecular formula C14H15Cl2N3O3
and a molecular weight of 344.20 g/mol. Its IUPAC name is 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide.
Analyze 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide?
The IUPAC name of 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide (CID 46943241) is 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide.
What is the SMILES notation for 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide?
The canonical SMILES for 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide is CC(C)Cc1nnc(NC(=O)COc2ccc(Cl)cc2Cl)o1.
What is the InChIKey of 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide?
The InChIKey is MSGRUUZPEBNOPE-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H15Cl2N3O3/c1-8(2)5-13-18-19-14(22-13)17-12(20)7-21-11-4-3-9(15)6-10(11)16/h3-4,6,8H,5,7H2,1-2H3,(H,17,19,20).
What are the key properties of 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide?
2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide has a molecular weight of 344.20 g/mol, XLogP of 3.59, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2,4-dichlorophenoxy)-N-[5-(2-methylpropyl)-1,3,4-oxadiazol-2-yl]acetamide is sourced from PubChem (CID 46943241), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).